Skip to main content
SpringerLink
Log in

Acute psychosis in systemic lupus erythematosus

  • Original Article
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

To evaluate the frequency and risk factors of acute psychosis in a large cohort of patients with systemic lupus erythematosous (SLE). To identify clinical and laboratory variables useful in differentiating acute psychosis as a primary manifestation of central nervous system (CNS) from corticosteroid induced psychosis. Five hundred and thirty seven consecutive patients with SLE were studied, with follow-up ranging from 4 to 8.8 years. A standardized medical history, neurological, rheumatologic, and psychiatric examinations and serologic testing were performed in all patients. The type and frequency of risk factors associated with acute psychosis as a primary manifestation of CNS system and corticosteroid induced psychosis was determined using multivariate regression with automatic backward stepwise selection. We identified acute psychosis in 89 of 520 (17.1%) SLE patients. Psychosis primary to CNS involvement was diagnosed in 59 of these patients, corticosteroid induced psychosis in 28 and primary psychotic disorder not related to SLE or medication in two patients. Psychosis secondary to SLE at disease onset occurred in 19 patients and was associated with disease activity (p = 0.001; OR = 2.4; CI = 1.5–6.2). Psychosis during follow-up of SLE was observed in 40 patients and associated with positive antiphospholipid antibodies (p = 0.004; OR = 3.2; CI = 1.9–4.5) and less frequently with renal (p = 0.002; OR = 1.9; CI = 0.0–0.6) and cutaneous (p = 0.04; OR = 1.1; CI = 0.0–0.8) involvement. We identified 28 patients with 38 episodes of psychosis associated with corticosteroid therapy. All the patients had severe active disease and ten of these patients had hypoalbuminemia when psychosis developed. At the time of psychotic event, all the patients were taking prednisone in doses varying from 0.75 to 1 mg/kg day−1. Psychosis resolved after tapering prednisone down in all patients. Acute psychosis related to SLE was observed in 11.3% of our cohort. Recurrence of primary psychosis was associated with other CNS manifestations related to SLE.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Jennekens FG, Kater L (2002) The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology (Oxford) 41:605–618

    Article  CAS  Google Scholar 

  2. Sanna G, Bertolaccini ML, Cuadrado MJ, et al (2003) Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies. J Rheumatol 30:985–992

    PubMed  Google Scholar 

  3. Mok CC, Lau CS, Wong RW (2001) Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 28:766–771

    PubMed  CAS  Google Scholar 

  4. Hebra F, Kaposi M (1874) On diseases of the skin, including the exanthemata, vol 4. In: Tay W, trans, Fragge CH (ed) New Sydenham Society, London pp 1866–1880

  5. Osler W (1900) The visceral lesions of the erythema group. Br J Dermatol 12:227–245

    Google Scholar 

  6. Tan EM, Cohen AS, Fries JF, et al (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25:1271–1277

    Article  PubMed  CAS  Google Scholar 

  7. Kassan SS, Kagan LJ (1979) Central nervous system lupus erythematosus: measurment of CSF cyclic GMP and other clinical markers of disease activity. Arthritis Rheum 22:449–457

    Article  PubMed  CAS  Google Scholar 

  8. Singer J, Denburg JA (1990) Ad Hoc neuropsychiatric lupus workshop group: diagnostic criteria for neuropsychiatric systemic lupus erythematosus: the result of a consensus meeting. J Rheumatol 17:1397–1402

    PubMed  CAS  Google Scholar 

  9. Brey RL, Holliday SL, Saklad AR, et al (2002) Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 58:1214–1220

    PubMed  CAS  Google Scholar 

  10. Kasitanon N, Louthrenoo W, Piyasirisilp S, Sukitawu W, Wichainun R (2002) Neuropsychiatric manifestations in Thai patients with systemic lupus erythematosus. Asian Pac J Allergy Immunol 20:179–185

    PubMed  Google Scholar 

  11. Patten SB, Neutel CI (2000) Corticosteroid-induced adverse psychiatric effects: incidence, diagnosis and management. Drug Saf 22:111–122

    Article  PubMed  CAS  Google Scholar 

  12. Boston Collaborative Drug Surveillance Program (1972) Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol Ther 13:694–698

    Google Scholar 

  13. Lopez-Medrano F, Cervera R, Trejo O, Font J, Ingelmo M (2002) Steroid induced psychosis in systemic lupus erythematosus: a possible role of serum albumin level. Ann Rheum Dis 61:562–563

    Article  PubMed  CAS  Google Scholar 

  14. Chau SY, Mok CC (2003) Factors predictive of corticosteroid psychosis in patients with systemic lupus erythematosus. Neurology 61:104–107

    PubMed  Google Scholar 

  15. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders. 4th edn.. APA, Washington

    Google Scholar 

  16. Liang MH, Corzillius M, Bae SC, et al (1999) The American College nomenclature and case definitions for neuropsychiatric lupus syndrome. Arthritis Rheum 42:599–608

    Article  Google Scholar 

  17. Bombardier C, Gladman DD, Urowitz M, Caron D, Chang C (1992) Derivation of the SLEDAI: a disease activity index for lupus patients. Arthritis Rheum 35:630–640

    Article  PubMed  CAS  Google Scholar 

  18. Gladman DD, Urowitz MB, Goldsmith CH, Fortin P, Ginzler E, Gordon C, Hanly JG, et al (1987) The reliability of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus. Arthritis Rheum 40:809–813

    Article  Google Scholar 

  19. Folstein MF, Folstein SE, Folstein PR (1975) “Mini mental state” a practical method for grading the cognitive state of patient for the clinician. J Psychiatr Res 12:189–198

    Article  PubMed  CAS  Google Scholar 

  20. Spranoel HZ (1992) The psychoeducational use and interpretation of the Wechsler adult intelligence scale––revised. CC Thomas, Springfield

    Google Scholar 

  21. Wechsler (1986) In Muistiasteikko, Suom. Anja Manner. Psykologien Kustannus, Helsinki

  22. Delis DC, Kramer JH, Kaplan E, et al (1987) California verbal learning test research edition manual. Psychological Corporation, San Antonio

    Google Scholar 

  23. Lezak MD (1995) Neuropsychological assessment. Oxford University Press, New York

    Google Scholar 

  24. Heaton RK, Chelune GJ, Talley JL, et al (1993) Wisconsin card sorting test manual, revised and expanded. Psychological Assessment Resources, Odessa

    Google Scholar 

  25. Beck AT, Beamesderfer A (1974) Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry 7:151–169

    PubMed  CAS  Google Scholar 

  26. Beck AT, Rial WY, Rickels K (1974) Short form of depression inventory: cross-validation. Psychol Rep 34:1184–1186

    PubMed  CAS  Google Scholar 

  27. Herrmann C (1997) International experiences with the hospital anxiety and depression scale––a review of validation data and clinical results. J Psychosom Res 42:17–41

    Article  PubMed  CAS  Google Scholar 

  28. Overall JE, Beller SA (1984) The brief psychiatric rating scale (BPRS) in geropsychiatric research: I. Factor structure on an inpatient unit. J Gerontol 39:187–93

    PubMed  CAS  Google Scholar 

  29. Harris EN, Gharavi AE, Patel SP, Hughes GR (1987) Evaluation of the anticardiolipine antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 68:215–222

    PubMed  CAS  Google Scholar 

  30. Brandt JT, Triplett DA, Scharer I (1995) Criteria for the diagnosis of lupus anticoagulant: an update. Thromb Haemost 74:1185–1190

    PubMed  CAS  Google Scholar 

  31. Fernandez Ga de Las Heras V, Gorriti MA, Garcia-Vicuna R, Santos Ruiz JL (2007) Psychosis leading to the diagnosis of unrecognized systemic lupus erythematosus: a case report. Rheumatol Int (in press)

  32. Hanly JG, Urowitz MB, Sanchez-Guerrero J, Bae SC, Gordon C, Wallace DJ, Isenberg D, et al (2007) Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 7(56):265–273

    Article  Google Scholar 

  33. Wysenbeek AJ, Leibovici L, Zoldan J (1990) Acute central nervous system complications after pulse steroid therapy in patients with SLE. J Rheumatol 17:1695–1696

    PubMed  CAS  Google Scholar 

  34. Lewis GP, Jusko WJ, Graves L, Burke CW (1971) Prednisone side-effects and serum-protein levels. A collaborative study. Lancet 2:778–780

    Article  PubMed  CAS  Google Scholar 

  35. Kohen M, Asherson RA, Gharavi AE, Lahita RG (1993) Lupus psychosis: differentiation from the steroid-induced state. Clin Exp Rheumatol 11:323–326

    PubMed  CAS  Google Scholar 

  36. Sirois F (2003) Steroid psychosis: a review. Gen Hosp Psychiatry 25:27–33

    Article  PubMed  Google Scholar 

  37. Reichlin M (2003) Ribosomal P antibodies and CNS lupus. Lupus 12:916–918

    Article  PubMed  CAS  Google Scholar 

  38. Isshi K, Hirohata S (1998) Differential roles of the anti-ribosomal P antibody and antineuronal antibody in the pathogenesis of central nervous system involvement in systemic lupus erythematosus. Arthritis Rheum 41:1819–1827

    Article  PubMed  CAS  Google Scholar 

  39. Toubi E, Shoenfeld Y (2007) Clinical and biological aspects of anti-P-ribosomal protein autoantibodies. Autoimmun Rev 6:119–125

    Article  PubMed  CAS  Google Scholar 

  40. Zandman-Goddard G, Chapman J, Shoenfeld Y (2007) Autoantibodies involved in neuropsychiatric SLE and antiphospholipid syndrome. Semin Arthritis Rheum (in press)

  41. Karassa FB, Afeltra A, Ambrozic A, Chang DM, De Keyser F, Doria A, Galeazzi M, Hirohata S, Hoffman IE, Inanc M, Massardo L, Mathieu A, Mok CC, Morozzi G, Sanna G, Spindler AJ, Tzioufas AG, Yoshio T, Ioannidis JP (2006) Accuracy of anti-ribosomal P protein antibody testing for the diagnosis of neuropsychiatric systemic lupus erythematosus: an international meta-analysis. Arthritis Rheum 54:312–24

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Rheumatology Unit, State University of Campinas, Campinas, São Paulo, Brazil

    Simone Appenzeller & Lilian Tereza Lavras Costallat

  2. Neuroimaging Lab, State University of Campinas, Campinas, São Paulo, Brazil

    Simone Appenzeller & Fernando Cendes

  3. Department of Neurology, State University of Campinas, Campinas, São Paulo, Brazil

    Fernando Cendes

  4. Montreal Neurological Institute, 3801 University, suite WB 325, Montreal, QC, Canada, H3A-2B4

    Simone Appenzeller

Authors
  1. Simone Appenzeller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fernando Cendes
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lilian Tereza Lavras Costallat
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Simone Appenzeller.

Additional information

Grants: Fundação de Amparo a Pesquisa do Estado de São Paulo (FAPESP), Conselho Nacional de Pesquisa e Desenvolvimento (CNPq).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Appenzeller, S., Cendes, F. & Costallat, L.T.L. Acute psychosis in systemic lupus erythematosus. Rheumatol Int 28, 237–243 (2008). https://doi.org/10.1007/s00296-007-0410-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-007-0410-x

Keywords

Search

Navigation